From passengers to co-pilots: Patient roles expand

Science Translational Medicine

Volumn 7, Issue 291, 2015, Pages

  Anderson, Margaret ^a   McCleary, K Kimberly ^a  

^a FasterCures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO CHANGE; BIOTECHNOLOGY; CYSTIC FIBROSIS; DECISION MAKING; DISEASE COURSE; DOCTOR PATIENT RELATION; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE POLICY; HISTORY; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAW ENFORCEMENT; MEDICAL CARE; MEDICAL RESEARCH; MENTAL HEALTH; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT PARTICIPATION; POLIOMYELITIS; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; RISK BENEFIT ANALYSIS; SHORT SURVEY; UNITED STATES; POLICY; SOCIAL BEHAVIOR; TRENDS;

HUMANS; PATIENT CARE; PATIENT PARTICIPATION; POLICY; SOCIAL RESPONSIBILITY;

EID: 84930789563     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aac6023     Document Type: Short Survey

References (10)

1. L. Kish, The blockbuster drug of the century: An engaged patient. HL7 Health Standards 28 August 2012. www.hl7standards.com/blog/2012/08/28/drug-of-the-century.
2. Drug discovery and development, Understanding the R&D process (PhRMA, Washington, DC, 2007).
3. M. Anderson, M. Manganiello, Back to basics: HIV/AIDS Advocacy as a Model for Catalyzing Change (FasterCures, Washington, DC, 2011).
4. 21st Century Cures Act discussion document (U.S. House of Representatives, Washington, DC, 2015). http://energycommerce.house.gov/sites/republicans. energycommerce.house.gov/files/114/Analysis/Cures/20150127-Cures-Discussion-Document-One- Pager.pdf.
5. 21st Century Cures Act discussion draft (U.S. House of Representatives, Washington, DC, 2015). http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/114/Analysis/Cures/20150127-Cures-Discussion-Document.pdf.
6. L. Alexander, R. Burr, Innovation for healthier Americans (U.S. Senate, Washington, DC, 2015). http://www.help. senate.gov/imo/media/Innovation-for-Healthier-Americans.pdf.
7. 21st Century Cures Act Discussion Draft (United States House of Representatives, Washington, DC, 2015). http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/fiiles/114/20150429DiscussionDraft.pdf
8. A. Hoos, J. Anderson, M. Boutin, L. Dewulf, J. Geissler, G. Johnston, A. Joos, M. Metcalf, J. Regnante, I. Sargeant, R. F. Schneider, V. Todaro, G. Tougas, Partnering with patients in the development and lifecycle of medicines: A call for action. Ther. Innov. Regul. Sci. 27 April 2015 (10.1177/21684790/5580384).
9. Patient preference information-Submission, review in PMAs, HDE applications, and de novo requests, and inclusion in device labeling draft guidance (FDA, Washington, DC, 2015). http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446680.pdf.
10. MDIC patient-centered benef t-risk project report: A framework for incorporating information on patient preferences regarding benef t and risk into regulatory assessments of new medical technology (MDIC, St. Louis Park, Minnesota, 2015).